MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Mineral water shows promise for fatty liver
Disease control CompletedThis study looked at whether drinking a mineral water rich in bicarbonate, sulfate, calcium, and magnesium could help people with a type of fatty liver disease called MASLD. 87 adults with MASLD were split into two groups: one drank the mineral water daily for a year along with a…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Team approach boosts weight loss in fatty liver disease
Disease control CompletedThis study tested a team-based approach for people with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a type of fatty liver linked to heart risks. 286 adults received either standard care or extra support from a liver doctor, a nutritionist, and a psychologist…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
Probiotics show promise for fatty liver in early trial
Disease control CompletedThis study tested whether three types of probiotics (Lactobacillus and Pediococcus strains) can improve liver health in people with non-alcoholic fatty liver disease. 89 adults took either a probiotic or a placebo daily for 8 weeks, along with a standard liver medication. Researc…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Chuncheon Sacred Heart Hospital • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
Hidden liver crisis: study reveals fatty liver rates in Turkey's At-Risk populations
Knowledge-focused CompletedThis study aimed to find out how common Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is among adults in Turkey who are at risk due to conditions like obesity, diabetes, or high blood pressure. Researchers used a special ultrasound-like test to check for liver …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC